Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Kraig W Jacobson"'
Autor:
Jennifer Schranz, Jim Christensen, Kraig W. Jacobson, Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, Yongqiang Tang, D. Soteres, Arthur Van Leerberghe, Moshe Y. Vardi, Peng Lu, Dumitru Moldovan, Sandra A. Nieto-Martinez
Publikováno v:
Pediatric Allergy and Immunology
Background Patients with hereditary angioedema with C1 inhibitor deficiency or dysfunction have burdensome recurrent angioedema attacks. The safety, efficacy, and health-related quality of life (HRQoL) outcomes of C1 inhibitor (C1-INH) prophylaxis (i
Autor:
Colette Kosik-Gonzalez, John C. Messina, Ramy A. Mahmoud, James N. Palmer, Per Gisle Djupesland, Kraig W. Jacobson
Publikováno v:
International Forum of Allergy & Rhinology. 8:869-876
BACKGROUND Inadequate efficacy of current intranasal steroids in chronic rhinosinusitis (CRS) is attributable to ineffective and/or inconsistent drug delivery to target anatomic sites. A new exhalation delivery system with fluticasone (EDS-FLU) may i
Autor:
Inmaculada Martinez-Saguer, James Hao, Jim Christensen, D. Soteres, Dumitru Moldovan, Arthur Van Leerberghe, Jennifer Schranz, Emel Aygören-Pürsün, Kraig W Jacobson
Publikováno v:
International Archives of Allergy and Immunology. 173:114-119
Background: Hereditary angioedema (HAE) is a rare genetic disease causing unpredictable and potentially life-threatening subcutaneous and submucosal edematous attacks. Cinryze® (Shire ViroPharma Inc., Lexington, MA, USA), a nanofiltered C1 inhibitor
Autor:
Hongzi Chen, William R. Lumry, H. Henry Li, Kraig W. Jacobson, Richard G. Gower, D. Soteres, Jennifer Schranz
Publikováno v:
Pediatric Allergy and Immunology. 26:674-680
Human plasma-derived nanofiltered C1 esterase inhibitor (C1 INH-nf) is used to treat acute angioedema attacks in patients with hereditary angioedema (HAE), but data regarding use in children are sparse.Patients 2 to12 years of age, body weight ≥10
Autor:
Kraig W. Jacobson, Melanie C. Wayne
Publikováno v:
Journal of Allergy and Clinical Immunology. 143:AB46
Autor:
S. Nieto-Martinez, Dumitru Moldovan, D. Soteres, J. Baptista, Kraig W. Jacobson, M. Vardi, Inmaculada Martinez-Saguer, Emel Aygören-Pürsün
Publikováno v:
Annals of Allergy, Asthma & Immunology. 121:S36
Introduction Adherence in a pediatric population can be a barrier to therapy. Here we report compliance, safety, efficacy and QoL outcomes in patients aged 6-11years who received intravenous (IV) C1-INH for routine prevention of angioedema attacks. M
Autor:
Richard L. Wasserman, Timothy J. Craig, Thomas Machnig, Againdra K. Bewtra, Kraig W. Jacobson, Robyn J. Levy
Publikováno v:
Allergy and Asthma Proceedings. 33:427-431
C1-inhibitor (INH) concentrate, which is recommended as first-line treatment for acute hereditary angioedema (HAE) attacks in many countries, was recently approved in the United States. We sought to solicit patients' feedback about their health-relat
Autor:
Timothy J. Craig, Thomas Machnig, Robyn J. Levy, James N. Moy, Mikhail Rojavin, Kraig W. Jacobson, D. Hurewitz, Againdra K. Bewtra, HO Keinecke, Richard L. Wasserman, F. Packer, J. Offenberger, Gerti Janss, S. L. Bahna, Frank J. Eidelman, Lynda C. Schneider, William H. Yang
Publikováno v:
Allergy. 66:1604-1611
To cite this article: Craig TJ, Bewtra AK, Bahna SL, Hurewitz D, Schneider LC, Levy RJ, Moy JN, Offenberger J, Jacobson KW, Yang WH, Eidelman F, Janss G, Packer FR, Rojavin MA, Machnig T, Keinecke H-O, Wasserman RL. C1 esterase inhibitor concentrate
Autor:
Robyn J. Levy, Jonathan A. Bernstein, Henriette Farkas, Janne Björkander, Murat Bas, Peter Schmid-Grendelmeier, David Resnick, Marco Cicardi, Charles H. Kirkpatrick, Marcus Maurer, Avner Reshef, Wolfhart Kreuz, Werner Aberer, Liying Dong, D. Hurewitz, William B Smith, Sonja Werner, Francesco Arcoleo, Shmuel Kivity, Conleth Feighery, William R. Lumry, William H. Yang, Jürgen Grabbe, Bruce Ritchie, Alejandro Malbrán, Konrad Bork, Gerald J. Gleich, Henning Bier, Thomas A. Luger, Marc A. Riedl, Duane Wombolt, Christiane Pichler, Hans F. Merk, Elias Toubi, Diego S. Fernández Romero, Martin Kaatz, Andrea Zanichelli, David Langton, Constance H. Katelaris, Christian Bull, Bernd Rosenkranz, Jens Greve, Ludovic Martin, Enrico Cillari, Thomas K. Hoffmann, Wing Tze Fan, Jens Zimmermann, Aleena Banerji, Kimberly Rosen, Paul K. Keith, Irina Kravec, Kraig W. Jacobson, Bernard Floccard, Laurence Bouillet, Krystyna Obtułowicz, Suresh Anné, Brigita Sitkauskiene, Jochen Knolle, F. Bracho, Jacques Hébert
Publikováno v:
New England Journal of Medicine. 363:532-541
BACKGROUND Hereditary angioedema is characterized by recurrent attacks of angioedema of the skin, larynx, and gastrointestinal tract. Bradykinin is the key mediator of symptoms. Icatibant is a selective bradykinin B2 receptor antagonist. METHODS In t
Autor:
Inmaculada Martinez-Saguer, Tom Tang, Arthur Van Leerberghe, Dumitru Moldovan, D. Soteres, Sandra Nieto–Martinez, Emel Aygören-Pürsün, Peng Lu, Kraig W. Jacobson, Jim Christensen
Publikováno v:
Journal of Allergy and Clinical Immunology. 141:AB46